Clinical Evidence
As an industry leader in innovative IV therapy products, we pride ourselves on achieving improved patient outcomes. Presented by healthcare professionals around the globe, this compilation of documents highlights how the I.V. House, Inc. products positively impact patient care.
An Evidence-based Practice Project to Improve Securement and Visualization of Peripheral Intravenous Catheters in Pediatric Patients
Cook Children's Hospital
At Cook Children's Hospital, both the small and large size I.V. House UltraDomes were included in a pilot implementation of a test kit that showed improved PIV outcomes and reduced costs in 6 areas over the course of 12 months' time.
Securing Tiny Veins: A PIVIE Task Force Intervention to Overcome Escalated Barriers to Best Practice
C.S. Mott Children's Hospital
A trial of the TLC Splint at C.S Mott Children's Hospital to reduce PIVIEs and patient harm, and to eliminate barriers to best practice. The task force and end users supported the transition to the proposed product, and I.V. House TLC Splints were approved for use in C.S. Mott Children’s Hospital.
Development of a Pediatric PIV Maintenance Bundle
Loma Linda University Children’s Hospital
A PIV maintenance bundle including the TLC Splint and the I.V. House UltraDome was found to be effective in maintaining PIV sites in children. Loss of PIV was significantly less when a maintenance bundle was used than when a bundle was not used.
Peer-to-Peer Rounding to Reduce the Number of Peripheral Intravenous Infiltrations and Extravasations
Children's Hospital of Wisconsin
Focused peer rounding demonstrated increased PIV insertion bundle compliance, sustained compliance, and reduced number of PIV moderate and severe infiltrates. Using nurse-driven peer-to-peer rounding and ADKAR was key to bundle compliance and reduction in the severity of patient harm.
Effectiveness of an Intravenous Protection Device in Pediatric Patients on Catheter Dwell Time and Phlebitis Score
Asian Nursing Research
The I.V. House UltraDressing is a useful device that can be used to increase catheter dwell time and protect and stabilize PIVCs in pediatric patients. This provides additional evidence-based support for the prolonged use of the I.V. House UltraDressing as a safe, easy-to-use, and effective device to protect or manage PIVCs in pediatric patients.
Reducing Complications of Intravenous Therapy In Infants and Toddlers
St. Louis Children's Hospital
A pilot implementation of the TLC Splint at St. Louis Children’s Hospital showed that the improved access to and visualization of the IV insertion site resulted in favorable outcomes in 7 defined criteria, totally eliminating infiltrations during the trial period.
Reduction in Infiltrates at a Major Pediatric Hospital / Proven Results from Across the U.S.
Multiple children’s hospital trials
Summary of results of trials at several children's hospitals across the U.S. Trials of the TLC Splint and I.V. House UltraDressing have shown fewer infiltrates, reduced catheter loss, increased dwell time, and overall reduction in patient harm. The products were also found to be easy to use and improved ease of assessment of the IV insertion site.